Cancer Immunotherapy: Decoding the Cancer Immunity Interactome - RESCHEDULING IN PROGRESS
Scientific Organizers: Charles Drake, Ira Mellman and Andrea Schietinger
Date: March 14 - 18, 2021
Location: Whistler Conference Centre, Whistler, BC, Canada
For important information on the coronavirus, please click here
Although our understanding of cancer immunity is advancing rapidly, the application of this evolving body of knowledge into effective immunotherapy treatments is impeded by the inherent challenge of keeping up with these advances, and divisions between basic research and clinical disciplines. Not only is the knowledge gap widening between basic mechanistic research and translational medicine, but also between research focused on disparate immune components, aspects of the tumor microenvironment and systems biology/bioinformatics approaches. Without the integration of these multi-dimensional perspectives into a coherent understanding of cancer immunity, we cannot hope to develop treatments that are effective in the complex context of human disease. This conference will bridge all of these fields, gathering experts from across these typically siloed areas who normally do not attend the same meetings or interact, with the goals of: (1) Fostering cooperation between systems biologists, basic and translational scientists such that bioinformatics discoveries can inform mechanistic and translational studies; (2) showcasing novel imaging and profiling technologies to promote widespread adoption by the field as a whole; (3) Bringing together scientists focused on disparate aspects of the TME (myeloid cells, dendritic cells, T cells) to envision a multi-dimensional model of cancer immunity. Attendees will be exposed to new technologies and systems biology approaches to advance and accelerate their own research efforts, as well as the field as a whole. Meanwhile, systems biologists will glean important insights into molecular mechanisms and clinical pathology to inform better models and approaches. Ultimately, by stimulated cross-talk in areas of expanding knowledge gaps, the program will seed fruitful exchange of information, ideas and tools to generate a comprehensive and holistic picture of cancer immunity. By initiating this collaborative environment, this meeting aims to accelerate basic research insights and translational impacts for more effective cancer immunotherapies.
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional support for this conference from: